Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Medroxyprogesterone
Drug ID BADD_D01365
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code G03AC06; G03DA02; L02AB02
DrugBank ID Not Available
KEGG ID D08166
MeSH ID D008525
PubChem ID 10631
TTD Drug ID D0I2SD
NDC Product Code 54348-805; 0009-0067
UNII HSU1C9YRES
Synonyms Medroxyprogesterone | (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione | Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- | 17 alpha-Hydroxy-6 alpha-Methylprogesterone | 17 alpha Hydroxy 6 alpha Methylprogesterone | Methylhydroxyprogesterone | Adgyn Medro
Chemical Information
Molecular Formula C22H32O3
CAS Registry Number 520-85-4
SMILES CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pruritus23.03.12.001--
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Purpura24.07.06.005; 23.06.01.004; 01.01.04.003--
Rash23.03.13.001--Not Available
Rectal haemorrhage07.12.03.001; 24.07.02.018--
Scleroderma23.03.02.005; 15.06.01.002; 10.04.07.001--Not Available
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Skin disorder23.03.03.007--Not Available
Skin odour abnormal23.03.03.012--
Somnolence19.02.05.003; 17.02.04.006--
Swelling08.01.03.015--Not Available
Syncope24.06.02.012; 17.02.04.008; 02.11.04.015--
Tachycardia02.03.02.007--Not Available
Tenderness08.01.08.005--Not Available
Tension19.06.02.005--Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Thrombophlebitis24.01.02.001--Not Available
Thrombosis24.01.01.006--Not Available
Unintended pregnancy18.08.01.001--Not Available
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urinary tract infection20.08.02.001; 11.01.14.004--
Urticaria23.04.02.001; 10.01.06.001--
Uterine leiomyoma16.04.02.001; 21.07.02.004--Not Available
Vaginal cyst21.08.03.003; 16.04.04.002--Not Available
Vaginal discharge21.08.02.002--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Vaginal infection21.14.02.002; 11.01.10.002--
Varicose vein24.10.04.001--Not Available
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene